Hepatocellular cancer is the most common type of primary liver cancer. Cirrhosis is the main risk factor that generates this malady. It has been proven that caloric restriction protocols and restricted feeding schedules are protective in experimental carcinogenic models. We tested the influence of a time-caloric restriction protocol (2 h of food access during the daytime for 18 weeks) in an experimental model of cirrhosis-hepatocarcinoma produced by weekly administration of diethylnitrosamine. Our results indicate that time-caloric restriction reduced hepatomegaly and prevented the increase in blood leukocytes promoted by diethylnitrosamine. Strikingly, time-caloric restriction preserved functional and histological characteristics of the liver in fibrotic areas compared to the cirrhotic areas of the Ad Libitum-fed group. Tumoural masses in the restricted group were well differentiated; consider a neoplastic or early stage of HCC. However, timecaloric restriction enhanced collagen deposits. With regard to the cancerous process, food restriction prevented systemic inflammation and an increase in carcinoembryonic antigen, and it favoured the occurrence of diffuse multinodular tumours. Histologically, it prevented hepatocyte inflammation response, the regenerative process, and neoplastic transformation. Time-caloric restriction stimulated circadian synchronization in fibrotic and cancerous liver sections, and it increased BMAL1 clock protein levels. We conclude that time-caloric restriction prevents fibrosis from progressing into cirrhosis, thus avoiding chronic inflammation and regenerative processes. It also prevents, probably through circadian entrainment and caloric restriction, the neoplastic transformation of tumoural lesions induced by diethylnitrosamine.
Introduction
Hepatocellular cancer (HCC) is the most frequent primary tumour in the liver (1) . Around 90% of clinical HCC cases show previous cirrhosis (2) . Cirrhosis is caused by a variety of chronic liver pathologies. It is accompanied by a change in the architecture of the liver with loss of function resulting from increased collagen synthesis and his deficient degradation. Cirrhosis development it is preceded by inflammation, apoptosis, and fibrosis processes that are accompanied by energy imbalance and oxidative damage induced by reactive oxygen species that frequently result in chromosomal instability (3) .
Treatment with diethylnitrosamine (DEN) is an experimental model used to replicate the sequence of cirrhosis and HCC in rats (4) . DEN is hydroxylated and bio-activated by hepatic CYP2E1 and CYP2A5 (5) , and it promotes: (i) formation of the mutagenic O6-ethylguanine-DNA adduct in DNA, (ii) proinflammatory and pro-fibrotic conditions, (iii) oxidative stress and (iv) regenerative processes. These effects lead to neoplastic transformation (4, 6) .
Epidemiological studies suggest that circadian rhythm disruption is an important risk factor for different types of cancer (7, 8) . Circadian rhythms are fluctuations in most of the biological parameters within a period of nearly 24 h (9). The human genome displays circadian variations in expression from 4 to 25% (10) . Many cellular processes, such as metabolism, cell cycle progression, stress response, DNA repair, and chromatin remodelling, show circadian rhythms, and their disruption is associated with carcinogenesis (9, 11) . The timing system consists of a set of interlocking transcriptional/ translational feedback loops known as the circadian molecular clock (CMC), which completes one cycle every 24 h and is located in every cell. The CMC is driven by core clock genes including bmal1, clock, per1, per2, cry1, cry2, and their corresponding proteins (10) .
It has been suggested that CMC is a tumour suppressor since cancerous cells show reduced expression of clock proteins, and mutated forms of these proteins have been associated with the carcinogenesis process (12, 13) . Disruption of the per1 and per2 genes causes dysfunction in cell cycle check-points and susceptibility to DNA damage associated with malignancies (13, 14) ; bmal1 +/-mice show an increased rate of spontaneous and radiation-induced neoplasia; mutated cry gen has a protective effect on mice expressing a mutant form of p53 (11) . Indeed, the overexpression of some clock proteins in cancer cells increases apoptosis and decreases their proliferation rate (15) .
Food availability and feeding schedules influence the timing system (16) . Synchronization by time-caloric restriction (T-CR) in rats involves daytime food access for 2 h. It induces the expression of the food entrained oscillator (FEO), which is a distributed circadian system formed by the communication between different brain areas and peripheral organs (9) . The T-CR protocol implies both the effects of food access schedules and a hypocaloric food intake (~30% less in comparison to Ad Libitum conditions) (17) . It induces changes in the acrophases of metabolic substrates (glycogen, fatty acids, triacylglycerides), hormones (insulin, ghrelin, glucocorticoids), inflammatory factors (NF-κB), and cellular events (cell cycle, apoptosis, metabolic pathways) (9) .
The aim of this study was to explore the potential protective role of the T-CR protocol against liver damage associated with the cirrhotic and carcinogenic action of chronic DEN treatment. The main findings were that T-CR prevented cirrhotic development, inhibited the neoplastic transformation of liver tissue, favored the daily synchronization of hepatic CMC under healthy and pathological conditions, and promoted the increase of BMAL1, in addition to avoiding chronic inflammation and develop of diffuse tumours.
Materials and methods

Experimental procedures
Animals and housing conditions
Male Wistar rats (200 ± 20 g) were kept on a 12 h light/12 h dark cycle (light on at 08:00 h; average light intensity 350 lux) at room temperature (~22 °C) with free access to food and water. Experimental procedures were conducted according to the Institutional Guide for the Care and Use of Animals Under Biomedical Experimentation (Universidad Nacional Autónoma de México) and conformed to international ethical standards (18) .
Treatment with diethylnitrosamine (DEN)
Rats treated with DEN (Sigma-Aldrich, México. N0756) received weekly i.p. injections of 50 mg/kg for 16 weeks, followed by 2 weeks without DEN treatment to avoid acute drug effects. This protocol induces fibrosis/cirrhosis and HCC after 12 and 16 weeks of DEN treatment, respectively (4). Control groups were injected i.p. with phosphate-buffered saline (PBS).
Experimental design
Rats were randomly assigned to one of the following 4 experimental groups (3 rats per cage) for 18 weeks: (i) Ad Libitum food access (AL); (ii) restricted feeding schedule limited manually to 2 h daily (from 12:00 to 14:00 h) (T-CR); (iii) AL food access, and DEN treatment (AL ± DEN); (iv) restricted mealtime schedule, and DEN treatment (T-CR ± DEN). All groups were fed with 5001 rodent diet (LabDiet, Brentwood, Missouri, USA). The experiments were replicated four times, and at least four rats per group were measured as follows: n = 9 in AL groups; n = 20 in AL + DEN group; n = 9 in T-CR group; n = 21 in T-CR + DEN group.
Somatometry and food intake
Food intake was manually quantified once a week at 14:00 h (after 24 h and 2 h of food access for the AL and T-CR groups, respectively). Body weight gain was measured once a week. The Lee index is an accepted parameter that was used to calculate rodent body mass at the end of the experiment (19) .
Blood and liver sampling
Rats were sacrificed by decapitation between 10:00 and 12:00 h before T-CR group mealtime. Trunk blood was collected in vacutainer tubes to obtain serum. Parameters of hepatic function, hematic biometry, liver damage, and tumoural markers were determined by standard spectrophotometric techniques used in clinical practice.
Macroscopic evaluation of cirrhosis and cancer
Each liver lobule was weighed, numbered, assigned a representative percentage of the total mass of liver, and the degree of fibrosis/cirrhosis developed was evaluated according to nodule size (20, 21) . Degree 0: Without apparent nodules; Degree I: Micronodular (<3 mm); Degree II: Medium nodules (3-5 mm); Degree III: Macronodular (>5 mm). Two types of tumour were observed after DEN treatment: HCC tumours (recognized as pale and solid masses) and cavernous hemangiomas (benign tumours) (Supplementary Figure S1) . DEN treatment caused two main kinds of HCC lesions: (i) Nodular: well-defined, single or multiple nodules. (ii) Diffuse: small tumour nodules extending diffusely within a lobe or throughout the entire liver. This micronodular character, extension and regularity can be confused with cirrhotic lesions (21) .
Tissue sampling and histology staining
Fragments of liver (1-3 mm 3 ) were dissected for histology. Tissue sections were fixed in 10% formalin and embedded in paraffin. Liver slices of 7 µm were stained using standard methods (Lee) (22) . Hematoxylin/eosin (H&E) staining was used to assess tissue integrity, architecture, cytology and inflammation using histopathologic criteria (23) . Masson Trichrome staining was used to outline collagen fibers. For electron microscopy, liver fragments (~3 mm 3 ) were fixed in 10% formalin and processed according to a previous report (24 
RT-qPCR analysis
Total liver RNA was isolated using the TRIzol method. cDNA for CYP2E1 was made with 1 μg of total RNA and M-MVL Retrotranscriptase following the manufacturer's instructions. qPCR was performed with TaqMan Master Mix, TaqMan probes for rat CYP2E1 (Rn00580624_m1), and β-actin (Rn00667869_m1) in a Corbett Rotor-Gene 6000 following the manufacturer's guide. Efficiency curves were made for each probe, and relative expression was calculated using 2-ΔCt mathematical analysis with the AL group as calibrator (30) .
Lipid peroxidation
Oxidative stress produced by DEN metabolism was measured using conjugate dienes and the thiobarbituric acid reactive substances (TBARS) assays to quantify lipoperoxidative grade in fibrotic/cirrhotic and tumoural sections of liver samples, as previously reported (31) .
Western blot analysis
Defined liver (~1 g) areas of healthy livers and areas showing evident cirrhotic nodules or cancerous masses in DEN treatment were homogenized (32) using the protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). Protein was quantified with the Bradford method (Bio-Rad, Hercules, CA, USA). Samples were placed on a 12% polyacrylamide gel under denaturing conditions. They were electroblotted onto a nitrocellulose membrane and then incubated overnight at room temperature with different primary antibodies: Anti-α1-Fetoprotein (ab46799, Abcam, CA, USA) at 1:1000 dilution, anti-PER1 (PAI-524, Thermo scientific, Rockford IL, USA) at 1:100 dilution, anti-BMAL1 (ab3350, Abcam, CA, USA) at 1:500 dilution, anti-CLOCK (PA1-520, Thermo scientific, Rockford IL, USA) at 1:200 dilution, and anti-β-actin (4967, Cell Signaling, USA) at 1:1000 dilution. Membranes were washed and incubated for 2 h at room temperature with alkaline phosphatase (AP) conjugated to the following secondary antibodies: donkey anti-mouse (sc-2320, Santa Cruz, CA, USA) at 1:1000 dilution and donkey anti-rabbit (ab97061, ab46799, Abcam, CA, USA) at 1:4000 dilution. Bands were visualized using the AP conjugate substrate kit (Bio-Rad, USA) according to the manufacturer's instructions. The Image Lab.Ink program was used for quantification.
Pictures
Pictures were taken using the Image-Pro Plus 6.0 program with ×20 and ×40 magnification.
Statistics
Data are presented as mean ± standard error of the mean (SEM). Data were compared using a two-way ANOVA for independent measures, with group factor and time factors in cases of weekly data, followed by Bonferroni post hoc tests with a significance threshold set at P < 0.05. The Student's t-test was done with the significance threshold set at P < 0.05. Statistical analyses were performed with GraphPad Prism 5 and graphs were made with SigmaPlot 10.0.
Results
Somatometry
T-CR rats were slimmer
The T-CR regimen promoted ~36% lower daily food intake ( Figure 1B ) leading to ~28% lower weight compared to the AL group after 18 weeks (marked with arrow in Figure 1A ). It also induced a ~6% reduction in the Lee index ( Figure 1C ).
DEN promoted weight reduction
The AL + DEN group weighed ~11% less than the AL group in week 7 (marked with arrow in Figure 1A ). By week 18, the AL-DEN group exhibited ~12% less weight ( Figure 1A ). In average, the AL + DEN group showed ~6% less daily food intake compared to the AL group ( Figure 1B ), but without changes in the Lee index ( Figure 1C ). The T-CR + DEN group, which weighed 12% and 17% less than the T-CR group at weeks 11 and 18, respectively (marked with arrow in Figure 1A ), ingested 16% less food per day ( Figure 1B ) without change in the Lee index ( Figure 1C ).
T-CR partially protected against hepatomegaly
Hepatomegaly and splenomegaly were observed in DENtreated groups: liver/body weight ratio in the AL + DEN group increased 180% in comparison to the AL group. In contrast, the T-CR protocol reduced hepatomegaly by 165% in the DEN group. Splenomegaly developed similarly in both DEN groups ( Figure 1D and E). The enlarged spleen is not a disease in itself, but it is a condition associated with portal system dysfunction promoted by the fibrotic/cirrhotic pathology.
Blood chemistry and liver function tests
T-CR preserved normal blood parameters
The T-CR protocol did not affect blood parameters, but it reduced urea nitrogen by 24% (Supplementary Figure S2B) . The mean corpuscular hemoglobin (MCH) level was 9% higher in the T-CR group than in the AL group (Supplementary Figure S2C) , suggesting that the nutritional state was not affected in rats under the T-CR protocol.
DEN promoted a compensated cirrhosis-like state
The AL + DEN group showed a 2.2-fold increase in total bilirubin (68% direct bilirubin and 32% indirect bilirubin), increases of 1.8 folds in alkaline phosphatase (AP) (Table 1C), 2.1 folds in alanine aminotransferase (ALT), 1.5 folds in aspartate aminotransferase (AST) and 3.9 folds in gamma-glutamyl transpeptidase (GGT) ( Table 1D ) compared with AL group. No significant changes were observed in biosynthetic and clotting functions (Table 1B) . These data suggest fibrosis/cirrhosis development after DEN treatment. The red blood cell fraction showed reductions in erythrocytes (6%), hemoglobin concentration (11%), hematocrits (12%) and medium corpuscular hemoglobin concentration (Supplementary Figure S2C) . These data indicate a compromised nutritional status in rats treated with DEN.
The T-CR + DEN group showed enhanced hyperbilirubinemia
The T-CR + DEN group showed increasing in AP 2.2 times (Table 1C) , ALT 2.5 times, AST 1.8 times, and GGT 2.2 compared whit T-CR group. One important difference was an increase of circulating bilirubin 4.6 folds compared with the T-CR group (75% direct bilirubin and 25% indirect bilirubin) (Table 1D) . No changes were observed in biosynthetic and clotting functions (Table 1B) . These data are also indicative of a compensated fibrotic/cirrhotic state but with reduced capacity of excretion in the T-CR + DEN group. In contrast to the AL + DEN group, all T-CR + DEN parameters related to red blood cells were normal (Supplementary Figure S2C) , indicating healthy nutritional conditions in spite of the reduced food intake.
DEN induced a pro-inflammatory state in the AL + DEN group
White blood cells (leukocytosis) in the AL + DEN group increased 80% compared to the AL group (Table 1E ). This effect is suggestive of a pro-inflammatory condition.
Anti-inflammatory effect of T-CR
T-CR + DEN rats had a normal white blood cell count, indicating that food restriction prevented the pro-inflammatory condition observed in the AL + DEN group (Table 1E ). The liver histopathological evaluation showed that macrophage and lymphocyte presence was 20% higher in the T-CR + DEN group than AL + DEN.
Fibrotic/cirrhotic state evaluation
It is important to clarify that 100% of rats treated with DEN developed some degree of fibrosis/cirrhosis and evidence of cancer.
The T-CR + DEN group showed more aggravated fibrotic macroscopic alterations
The macroscopic evaluation indicated that most of the AL + DEN rats (77%) developed Degree I and Degree II of macronodular fibrosis/cirrhosis. A smaller percentage (19%) did not present macroscopic cirrhotic lesions, and only 4% of the rats had severe cirrhotic damage (Degree III) (Figure 2A ). In contrast, T-CR + DEN rats showed a more accentuated macroscopic damage since 75% developed Degree II and Degree III of fibrotic/cirrhotic alterations.
The histological evaluation showed more collagen deposits in the T-CR + DEN rats
The Masson trichrome staining indicated in the AL + DEN group a decrease in sinusoids and space of Disse by an increase in cell proliferation. Collagen deposits were evident, as they covered the portal zone and fragmented the structure of the liver lobule with macro-and micro-nodulation in zones 1, 2 and 3. Hyperplasia and neo-formation of bile ducts were also evident ( Figure 2C and D, and Supplementary Figure S3 ). The T-CR + DEN group had more collagen deposits and thicker septa; it also presented alterations in tissue architecture, especially an enhanced neo-formation of bile ducts but with less dissociation of hepatocyte cords compared with the AL + DEN group, indicating that cell proliferation did not increase ( Figure 2C and D) .
Markers for hepatocarcinoma alteration
Circulating α-Fetoprotein (α-FP), GGT and carcinoembryonic antigen (CEA) were used as markers for HCC. α-FP and GGT increased significantly in both DEN-treated groups ( Figure 3A and B). In contrast, the T-CR protocol prevented a substantial rise in the CEA observed in AL + DEN rats (~51%) ( Figure 3C ). These results suggest that DEN stimulated cancerous development was not modified by the T-CR protocol. However, the CEA levels in the T-CR + DEN regime seem to indicate a reduction in the metastatic capacity of HCC.
HCC in the T-CR + DEN group is mostly diffuse
Tumour classification has been described based on macroscopic images. These classification systems generally require examination of the entire tumour and do not provide prognostic or predictive information by themselves, nor do they give clues that can explain pathogenesis. HCC can develop in different forms: (i) Uninodular, a single, well-defined tumour with a parenchymal-like aspect; (ii) multinodular, several well-defined tumours with a parenchymal-like aspect; (iii) massive, large tumour masses which can encompass an entire liver lobe; (iv) diffuse, a collection of small tumours distributed throughout the liver lobules (20) .
Macroscopic analysis showed that 75% of liver tumours in the AL + DEN group were multinodular, and only 15% were diffuse ( Figure 3D and E) . In contrast, tumours in the T-CR + DEN group were mostly diffuse (62%), and only 33% were multinodular; however, both types of tumours presented an early stage of carcinoma ( Figure 3D and E and Supplementary Figure S4) . Little is known about the characteristics of diffuse HCC because the cirrhotic phenotype is usually discovered in the final stage of the disease or post-mortem. Since T-CR clearly induces a change in the type of tumour, histopathological evaluation (degree of neoplastic un-differentiation) becomes relevant.
Histopatological evaluation of den-treated rat livers
H&E staining was used to characterize the degree of neoplastic transformation and cancer aggressiveness in DEN-treated rat livers. As expected, normal characteristics (hepatocytes with granular eosinophilic cytoplasm, and intact nuclei with welldefined nucleoli) were found in the AL and T-CR groups ( Figures  4 and Supplementary Figure S3) . 
Fibrotic/Cirrhotic histological fields
The H&E stains showed in the AL + DEN group large zones with pleomorphic hepatocytes; extensive areas with anisocytosis (evidence of the inflammatory state), the presence of fat vacuoles and granular eosinophilic cytoplasm. It also showed nuclei with reactive chromatin and a high incidence of dismembered nuclei, pyknosis and karyolysis. This group presented signs of necrosis, inflammation, and active cicatrization. In contrast, the T-CR + DEN group preserved its cellular and histological conditions with scarce regenerative fields and no evidence of inflammation ( Figures 4 and Supplementary Figure S3 ).
Cancerous histological fields
Tumoural zones in the AL + DEN group were clearly marked by connective tissue with frequent vascular infiltration; most cells looked un-differentiated (malignant cells) and were arranged in 
Cavernous hemangiomas
Surprisingly, DEN treatment also induced the formation of cavernous hemangiomas (benign tumours that were fluffy, reddish Uninodular, a liver with only one tumour mass that does not encompass all lobules; multinodular, a liver with two or more tumour masses that do not cover a complete lobe; massive, a liver with a large tumour mass that covers an entire lobe; diffuse, a liver with multinodular HCC development throughout the liver and a cirrhotic-like appearance. (E) Pictures that exhibit uninodular, multinodular, massive, and diffuse HCC development.
and had high blood vessel levels). Hemangiomas in the AL + DEN and T-CR + DEN groups were equal in number and size (data not shown).
Electron microscope evaluation
The AL group exhibited healthy hepatocytes with swollen mitochondria without obvious cristae, little endoplasmic reticulum, and large areas of cytosolic clear spaces without organelles. The T-CR group presented mitochondria with clear cristae and better membrane integrity. Strikingly, this group showed an increase in smooth endoplasmic reticulum (SER) and the formation of concentric cisternae covering ~50% of the cytoplasmic area. Nuclei in both groups presented reactive chromatin and prominent nucleoli ( Figure 4 and Supplementary Figure S3 ). Electron microscope study of fibrotic/cirrhotic sections Hepatocytes in the cirrhotic area of the AL + DEN group exhibited large sections without organelles in the cytosol; besides less SER with swelling and disrupted membranes, and no attached ribosomes. That hepatocytes presented fat vacuolization, pyknotic nuclei with slight indentations, and very reactive chromatin. Pleomorphic mitochondria presented loss of integrity in internal membranes (Supplementary Figure S5) . In contrast, the cirrhotic area of the T-CR + DEN group presented hepatocytes with larger mitochondria with less swelling, fewer pleomorphic alterations, and enhanced membrane integrity; also a large increase in SER with formation of concentric cisternae covering ~70% of the cytoplasmic area was observed. They also showed nuclei with few indentations, reactive chromatin and evident nucleoli (Supplementary Figure S5) .
Electron microscope study of cancerous sections
In the tumour areas, the AL + DEN group showed cells with a reduced nuclei/cytosol ratio with fewer mitochondria and a loss of inner membrane integrity. Cells contained less SER with swelling and disrupted cisternae (Supplementary Figure S5) . In contrast, the T-CR + DEN group showed swelling and pleomorphic cells that had small and pleomorphic mitochondria with better membrane integrity. Again, T-CR induced the formation of concentric cisternae in hepatocytes formed by SER, which covered ~70% of their cytoplasmic area; also showed nuclei with less indentations, reactive chromatin and evident nucleoli (Supplementary Figure S5) . These results suggest once more that tumours in the AL + DEN presented a more advanced degree of carcinogenesis than tumours in the T-CR + DEN group.
DEN bioactivation and liver pro-oxidant reactions
Since DEN-treated rat livers are mosaics of fibrotic/cirrhotic and tumoural areas, Western blotting was used to measure the presence of α-FP and determine whether each of the dissected hepatic segments was tumoural (high α-FP) or fibrotic/cirrhotic (low α-FP). α-FP levels in fibrotic/cirrhotic homogenates were the same as those in the groups not treated with DEN. However, α-FP was significantly higher (~15 folds) in the cancerous liver tissues of both DEN-treated groups ( Figure 5B ). We quantified CYP2E1 mRNA in the liver to test if T-CR could reduce DEN bio-activation and influence its hepatotoxic action. No differences were observed between the livers of DEN-treated animals. The expression of CYP2E1 mRNA was very low in cirrhotic sections and even lower in cancerous sections ( Figure 5A ), suggesting that DEN was metabolized equally in AL + DEN and T-CR + DEN groups.
Cancerous liver tissue in both DEN-treated groups showed a significant increase in conjugated dienes. However, this increase was not observed in the TBARS assay (Supplementary Figure S6) .
Synchronization of the circadian molecular clock
Tissues from the fibrotic/cirrhotic and tumour sections of the liver were tested to determine the presence of clock proteins ( Figure 5 ) and learn whether the T-CR protocol could entrain the CMC. Liver samples were collected from 10:00 h to 12:00 h in all groups; therefore, high levels of PER1 were expected in T-CR groups and lower levels were expected in AL groups (17, 33) . Indeed, Figure 5D shows that PER1 levels in the T-CR group were higher (~180%) than in the AL group. Strikingly, PER1 increased in the fibrotic/cirrhotic and tumoural liver fragments (~100-145%) by T-CR synchronization. These results indicate that T-CR entrained the CMC, even in the cirrhotic and tumoural sections of the livers ( Figure 5D ).
BMAL1 protein levels increased in T-CR tumours compared to AL + DEN tumours (300%); Furthermore BMAL1 was increased 333% compared with T-CR and 355% compared with T-CR + DEN cirrhotic areas ( Figure 5E ). CLOCK expression remained the same in both healthy and DEN-treated groups ( Figure 5C ). These data suggest that the T-CR protocol sustained CMC entrainment even after the liver had been altered by cirrhotic and cancinogenic processes.
Summary of results
Supplementary Figure 7 summarizes all results related to fibrotic/cirrhotic damage and HCC development, and the protection associated to the T-CR protocol.
Discussion
The use of DEN to induce fibrosis/cirrhosis and HCC is a convenient model to study and replicate the clinical condition. It is important to clarify that all DEN-treated rat livers had a mosaic-like appearance because they developed some degree of fibrosis/cirrhosis, pre-neoplastic and neoplastic areas; hence, histopathological evaluation was fundamental.
In this study, we used food access and time-caloric restriction to better understand how this protocol can be used as a potential therapeutic tool.
Systemic and tissue-specific disruption of the circadian machinery leads to changes in cellular functions, such as cell division and metabolism, which are highly related to cancer. Emerging evidence in different cellular and in vivo models points to an important role of core circadian genes in carcinogenesis. It is unclear how oncogenic events may cooperate with circadian clock disruption during cancer initiation and progression (12) .
Time-caloric restriction as a synchronizer
Rats under the T-CR protocol for 3 weeks ate ~36% less than AL rats (17) . T-CR is a synchronizing protocol that involves two variables: A feeding schedule and calorie restriction (9) .
Timed feeding can reset peripheral oscillator phases with minor effects on SCN clockwork phases when animals are synchronized by light-dark cycles. Daytime food deprivation and calorie restriction lead to loss of body mass (˃15%) and increased motor activity; they also affect the timing of daily activity, as nocturnal animals become partially diurnal (34) . T-CR synchronizes liver CMC: it shifts the PER1 peak to the feeding schedule in the light period (33) and the BMAL1 peak to the dark period (17) . Moreover, both peaks are in antiphase compared to the AL group.
As previously reported, T-CR affects liver metabolism; it increases β-oxidation and ketogenesis, upregulates gluconeogenic responses, intensifies mitochondrial activity and modifies daily profile of ATP synthesis (9, (35) (36) (37) (38) . In addition, hepatic energy charge increases during T-CR, whereas cytoplasmic and mitochondrial redox states become oxidized (9) . We have ruled out that T-CR induces an acute phase response (33) that increases apoptosis and cell cycle rates without loss homeostasis (39) . These changes, produced by T-CR synchronization, might affect the initiation, development, and progression of cancer.
T-CR prevents fibrosis progression
The AL + DEN group developed clearly cirrhosis because it exhibited collagen deposits, chronic inflammation, oxidative stress and regenerative processes. Despite having more collagen deposits and equal oxidative stress levels, the T-CR + DEN group only developed fibrosis due to the absence of chronic inflammation and uncontrolled regenerative processes. Furthermore, the optimum liver function and nutritional condition in the T-CR + DEN group prevented the fibrosis from developing into cirrhosis. Since it has been reported that hypocaloric protocols exacerbate pro-fibrotic treatments increasing collagen deposits, we can relate the increase of collagen to caloric restriction (40) .
DEN-treated rats held under constant lighting showed more severe carcinogenic hepatic damage, although the precise induction mechanism is unclear (41).
Anti-inflammatory effect of T-CR
Inflammatory responses play decisive roles at different stages of tumour development, from initiation to metastasis. Inflammation also affects immune surveillance and responses to anti-oncogenic therapy. Caloric restriction in mammals is recognized as the best strategy for extending life span, retarding physiological aging and delaying the onset of age-associated diseases (42) .
T-CR preserved the histological properties of the liver and prevented its neoplastic transformation
Although the number and size of the tumours indicate a pathological condition, neoplastic transformation is the best indicator of cancer aggressiveness. Therefore, histopathological evaluation was essential for this study. The anti-inflammatory effect of T-CR (Table 1E) can be a crucial deterrent of the neoplastic transformation of tumours (Figure 4) .
Tumoural cells in the AL + DEN group showed clear characteristics of an advanced neoplastic phenotype (Figure 4 and Supplementary Figure S4) , consistent with the increase in CEA (marker of metastatic state) ( Figure 3C ). The normal levels of circulating CEA in the T-CR + DEN group suggest a lower degree of neoplastic transformation, which was confirmed by histological and electron microscope evaluations (Figures 3 and 4 , and Supplementary Figure S5) . Overall, the T-CR + DEN group preserved the hepatocyte phenotype and avoided neoplastic transformation, as the areas with damage remained in the early stage of HCC or did not exhibit neoplastic changes.
Nutritional state
Caloric restriction (CR) is an experimental manipulation focused on reducing calorie intake without causing malnutrition, and that induces life span extension in many species; but the underlying mechanism that modifies aging, inflammation and metabolism is unclear (42) (43) (44) . That effect could involve the interaction of insulin/IGF1-like growth factor, AMPK, mTOR signaling pathways, and the sirtuin protein family (42, 43) . CR also influences the functional and molecular link between energy balance, chromatin remodeling, and circadian physiology (43, 44) .
Nutritional data for our T-CR protocol (using albumin, hemoglobin concentration, and mean corpuscular hemoglobin) (Table 1B and Supplementary Figure S2 ) indicate a normal state in spite of the significant reduction in food intake (~36%), suggesting a CR without malnutrition (typically 20-40% of AL consumption).
DEN treatment alone reduced weight gain by 22% in AL rats ( Figure 1A ) with signs of anemia (reduced albumin, hemoglobin concentration, and mean corpuscular hemoglobin) (Table 1B and Supplementary Figure S2) . In contrast, the T-CR + DEN group showed a normal nutritional state ( Figure 1C , Table 1B , and Supplementary Figure S2) .
DEN metabolism
Since the levels of the CYP2E1 mRNA were not altered ( Figure 5A ) and similar pro-oxidative activity was observed in cirrhotic and tumoural samples of the AL + DEN and T-CR + DEN groups (Supplementary Figure S6) , it could be ruled out that the protective effects associated with the T-CR protocol were caused by alterations in DEN bioactivation. It has been shown that clock genes play an important role in DEN-induced cytotoxicity and in the susceptibility to apoptosis in drug-treated hepatocytes (5). Our results did not reveal changes in hepatic CLOCK signals ( Figure 5C ). Indeed, the molecular mechanism whereby circadian clock alterations influence cancer development and progression could be explained by its regulation of the cell cycle, as well as by DNA damage responses and cellular metabolism (44) .
Circadian physiology as a counteractive mechanism of neoplastic transformation
As previously mentioned, CMC measures time and allows synchronization to different stimuli; however, recent studies prove that CMC also has antineoplastic effects. It has been discovered that BMAL1 could bind directly to the p53 gene promoter, thereby transcriptionally activating the downstream tumour suppressor pathway, increasing apoptosis levels, and decreasing cellular proliferation in pancreatic cancer (15) .
Meal timing can reset CMC in peripheral tissues, thus slowing the growth of tumoural masses and producing fewer and smaller tumours. For example, Wu et al. (45) revealed that food restriction reduced the progression of inoculated Glasgow osteosarcoma. They compared mice fed AL to mice with restricted access to food for 4-6 h during the light and dark periods. Both restricted feeding conditions improved survival and delayed tumoural growth compared to the AL group, but the protective effect was more significant when food restriction was applied during the light period.
Chronotherapy has emerged as a therapeutic strategy that applies knowledge about how circadian rhythms can potentiate the effect of anti-cancer drugs (46, 47) . Identifying the best treatment schedule makes it possible to obtain similar or better results with reduced drug doses (46, 47) . Since circadian rhythmicity modulates the sensitivity of many therapeutic cytotoxic targets, controlling meal times might increase treatment efficacy (5).
Isolated hepatocellular carcinoma cells are capable of generating circadian rhythms in vitro (5) . Temporal day-night restriction of food alters the phase of rhythms in both healthy and malignant tissues. However, hepatomas were more sensitive to food intake signals depending on meal times (5) .
It has been shown that BMAL1 acts as a potential antioncogene in pancreatic cancer by activating the p53 tumour suppressor pathway, thereby inducing apoptosis and cell cycle arrest (15) . These findings suggest that the T-CR-induced BMAL1 increase would be a useful target to continue researching about how T-CR affects HCC development.
In conclusion, the T-CR protocol reduced the underlying damage produced by DEN treatment (Figure 7) . It also modified fibrotic/cirrhotic and HCC development sequences, thus preventing chronic inflammation and neoplastic transformation, and preserving liver function and nutritional state. T-CR was able to maintain cirrhosis and HCC entrainment. The data support the notion that both the CR and circadian entrainment involved in T-CR could be important in the protective mechanism. The T-CR protocol could be considered a potential factor in strengthening current or future therapeutic approaches to ameliorate the development of cancerous processes.
Supplementary Material
Supplementary data are available at Carcinogenesis online.
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